Literature DB >> 33445874

The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Mukaddes Izci1, Christy Maksoudian1, Bella B Manshian2, Stefaan J Soenen1.   

Abstract

Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a decade. Classically, scientists have tried to improve NM delivery by employing passive or active targeting strategies, making use of the so-called enhanced permeability and retention (EPR) effect. This phenomenon is made possible due to the leaky tumor vasculature through which NMs can leave the bloodstream, traverse through the gaps in the endothelial lining of the vessels, and enter the tumor. Recent studies have shown that despite many efforts to employ the EPR effect, this process remains very poor. Furthermore, the role of the EPR effect has been called into question, where it has been suggested that NMs enter the tumor via active mechanisms and not through the endothelial gaps. In this review, we provide a short overview of the EPR and mechanisms to enhance it, after which we focus on alternative delivery strategies that do not solely rely on EPR in itself but can offer interesting pharmacological, physical, and biological solutions for enhanced delivery. We discuss the strengths and shortcomings of these different strategies and suggest combinatorial approaches as the ideal path forward.

Entities:  

Year:  2021        PMID: 33445874      PMCID: PMC7883342          DOI: 10.1021/acs.chemrev.0c00779

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


  505 in total

1.  The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles.

Authors:  Helen Lee; Humphrey Fonge; Bryan Hoang; Raymond M Reilly; Christine Allen
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

2.  Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands.

Authors:  P M Peiris; F He; G Covarrubias; S Raghunathan; O Turan; M Lorkowski; B Gnanasambandam; C Wu; W P Schiemann; E Karathanasis
Journal:  Nanoscale       Date:  2018-04-19       Impact factor: 7.790

3.  Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.

Authors:  Sally J DeNardo; Gerald L DeNardo; Laird A Miers; Arutselvan Natarajan; Alan R Foreman; Cordula Gruettner; Grete N Adamson; Robert Ivkov
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

Review 4.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 5.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

6.  Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.

Authors:  Clifford J Whatcott; Haiyong Han; Richard G Posner; Galen Hostetter; Daniel D Von Hoff
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

7.  Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors.

Authors:  Tsutomu Nakahara; Scott M Norberg; David R Shalinsky; Dana D Hu-Lowe; Donald M McDonald
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.

Authors:  Sheng Tan; Guoxiang Wang
Journal:  Biomed Pharmacother       Date:  2018-03-15       Impact factor: 6.529

9.  Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.

Authors:  Adam J Gormley; Alexander Malugin; Abhijit Ray; Ryan Robinson; Hamidreza Ghandehari
Journal:  J Drug Target       Date:  2011-12       Impact factor: 5.121

10.  Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization.

Authors:  Josef Ehling; Benjamin Theek; Felix Gremse; Sarah Baetke; Diana Möckel; Juliana Maynard; Sally-Ann Ricketts; Holger Grüll; Michal Neeman; Ruth Knuechel; Wiltrud Lederle; Fabian Kiessling; Twan Lammers
Journal:  Am J Pathol       Date:  2013-11-18       Impact factor: 4.307

View more
  25 in total

1.  Supramolecular "Click Chemistry" for Targeting in the Body.

Authors:  Christopher J Addonizio; Brant D Gates; Matthew J Webber
Journal:  Bioconjug Chem       Date:  2021-08-20       Impact factor: 6.069

Review 2.  Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect.

Authors:  Victor Ejigah; Oluwanifemi Owoseni; Perpetue Bataille-Backer; Omotola D Ogundipe; Funmilola A Fisusi; Simeon K Adesina
Journal:  Polymers (Basel)       Date:  2022-06-27       Impact factor: 4.967

Review 3.  An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment.

Authors:  Majid Sharifi; William C Cho; Asal Ansariesfahani; Rahil Tarharoudi; Hedyeh Malekisarvar; Soyar Sari; Samir Haj Bloukh; Zehra Edis; Mohamadreza Amin; Jason P Gleghorn; Timo L M Ten Hagen; Mojtaba Falahati
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

4.  A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization.

Authors:  Tingting Yang; Yuzhu Hu; Junming Miao; Jing Chen; Jiagang Liu; Yongzhong Cheng; Xiang Gao
Journal:  Acta Pharm Sin B       Date:  2022-02-16       Impact factor: 14.903

5.  Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models.

Authors:  Arindam Pramanik; Zexi Xu; Shazana H Shamsuddin; Yazan S Khaled; Nicola Ingram; Thomas Maisey; Darren Tomlinson; P Louise Coletta; David Jayne; Thomas A Hughes; Arwen I I Tyler; Paul A Millner
Journal:  ACS Appl Mater Interfaces       Date:  2022-02-23       Impact factor: 10.383

Review 6.  Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments.

Authors:  Seungyong Shin; Jiyoung Lee; Jieun Han; Fangyuan Li; Daishun Ling; Wooram Park
Journal:  Tissue Eng Regen Med       Date:  2021-10-21       Impact factor: 4.451

7.  Systematic design of cell membrane coating to improve tumor targeting of nanoparticles.

Authors:  Lizhi Liu; Dingyi Pan; Sheng Chen; Maria-Viola Martikainen; Anna Kårlund; Jing Ke; Herkko Pulkkinen; Hanna Ruhanen; Marjut Roponen; Reijo Käkelä; Wujun Xu; Jie Wang; Vesa-Pekka Lehto
Journal:  Nat Commun       Date:  2022-10-19       Impact factor: 17.694

Review 8.  Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy.

Authors:  Xiaoling Ding; Xinchen Sun; Huihui Cai; Lei Wu; Ying Liu; Yu Zhao; Dingjingyu Zhou; Guiping Yu; Xiaorong Zhou
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

Review 9.  Stereocomplex Polylactide for Drug Delivery and Biomedical Applications: A Review.

Authors:  Seung Hyuk Im; Dam Hyeok Im; Su Jeong Park; Justin Jihong Chung; Youngmee Jung; Soo Hyun Kim
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

Review 10.  Polymer-Based Nanofiber-Nanoparticle Hybrids and Their Medical Applications.

Authors:  Mingxin Zhang; Wenliang Song; Yunxin Tang; Xizi Xu; Yingning Huang; Dengguang Yu
Journal:  Polymers (Basel)       Date:  2022-01-17       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.